Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial. Gu Y. Lancet 2024;404:338.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gu Y. Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial. Lancet 2024;404:338.
PMID: 39067899